Author
Listed:
- Ruihua Ma
(Tongji Medical College, Huazhong University of Science and Technology)
- Wanguang Zhang
(Tongji Medical College, Huazhong University of Science and Technology)
- Ke Tang
(Tongji Medical College, Huazhong University of Science and Technology)
- Huafeng Zhang
(Tongji Medical College, Huazhong University of Science and Technology)
- Yi Zhang
(Tongji Medical College, Huazhong University of Science and Technology)
- Dapeng Li
(Tongji Medical College, Huazhong University of Science and Technology)
- Yong Li
(Tongji Medical College, Huazhong University of Science and Technology)
- Pingwei Xu
(Tongji Medical College, Huazhong University of Science and Technology)
- Shunqun Luo
(Tongji Medical College, Huazhong University of Science and Technology)
- Wenqian Cai
(Tongji Medical College, Huazhong University of Science and Technology)
- Tiantian Ji
(Tongji Medical College, Huazhong University of Science and Technology)
- Foad Katirai
(Tongji Medical College, Huazhong University of Science and Technology)
- Duyun Ye
(Tongji Medical College, Huazhong University of Science and Technology)
- Bo Huang
(Tongji Medical College, Huazhong University of Science and Technology
National Key Laboratory of Medical Molecular Biology, Chinese Academy of Medical Sciences)
Abstract
Gluconeogenesis is a fundamental feature of hepatocytes. Whether this gluconeogenic activity is also present in malignant hepatocytes remains unexplored. A better understanding of this biological process may lead to novel therapeutic strategies. Here we show that gluconeogenesis is not present in mouse or human malignant hepatocytes. We find that two critical enzymes 11β-HSD1 and 11β-HSD2 that regulate glucocorticoid activities are expressed inversely in malignant hepatocytes, resulting in the inactivation of endogenous glucocorticoids and the loss of gluconeogenesis. In patients’ hepatocarcinoma, the expression of 11β-HSD1 and 11β-HSD2 is closely linked to prognosis and survival. Dexamethasone, an active form of synthesized glucocorticoids, is capable of restoring gluconeogenesis in malignant cells by bypassing the abnormal regulation of 11β-HSD enzymes, leading to therapeutic efficacy against hepatocarcinoma. These findings clarify the molecular basis of malignant hepatocyte loss of gluconeogenesis and suggest new therapeutic strategies.
Suggested Citation
Ruihua Ma & Wanguang Zhang & Ke Tang & Huafeng Zhang & Yi Zhang & Dapeng Li & Yong Li & Pingwei Xu & Shunqun Luo & Wenqian Cai & Tiantian Ji & Foad Katirai & Duyun Ye & Bo Huang, 2013.
"Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma,"
Nature Communications, Nature, vol. 4(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3508
DOI: 10.1038/ncomms3508
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3508. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.